Canada, July 30, 2019 (PROACTIVEINVESTORS USA)- The new appointments come as the medical cannabis company advances its efforts to pursue development of CBD-based therapies to replace widely used opioid painkillers in treatment programs. Dr Kaiser was named one of the 50 most influential health executives in 2019 FSD Pharma Inc (CSE:HUGE) …
Read More »
Canda, July 26, 2019 (STOCKHOUSE)- The Arcview Chicago Investor Forum blew into the windy city of Chicago last week, where institutional and high-net-worth investors, industry leaders, and curated early and growth stage cannabis companies gathered to get deals done. Held over three days at the Fairmont Chicago, the Forum offered …
Read More »
Australia, July 26, 2019 (HEMPGAZETTE)- The UK’s only organic hemp farming co-operative, Hempen, began destroying its hemp crop in Oxfordshire earlier this week as a result of having its licence cancelled. Hempen Co-operative was founded as a not-for-profit organisation in 2015. It produces hemp seed oil, hemp tea, moisturising oils …
Read More »
Canda, June 10, 2019 (BOTANIQMAG)- The first registered charity in the world focused on medical cannabis launched has launched with a goal of empowering patients by helping Canadians overcome financial barriers to medical cannabis within the regulated market. The organization is called Hope for Health, and through charitable donations, its financial …
Read More »
FSD Pharma CEO Raza Bokhari said the company plans on uplisting at a major U.S. exchange. He spoke with Green Market Report’s Debra Borchardt at the MJ Link Micro Investor conference in New York on June 25.
Read More »
U.S, July 17, 2019 (MARIJUANA BUSNESS DAILY)- Many wholesale cannabis growers choose to compete on quality, even while market forces favor growers who can reliably supply low-cost cannabis. Nearly half of U.S. cultivators are attempting to make high-quality flower their key differentiator, according to the recently released 2019 Marijuana Business …
Read More »
Thailand, July 18, 2019 (BLOOMBERG BUSNESSWEEK)- The forecast for the legal cannabis market in Asia is rosy—it’s expected to swell to $8.5 billion by 2024 from practically nothing today. One of the main questions surrounding this potential market is which country will establish an early lead as a supplier. Surprisingly, …
Read More »
UK, July 18, 2019 (ANALYTICAL CANNABIS)- Cannabidiol (CBD) should be investigated as a treatment for Angelman syndrome in humans, say scientists from the University of North Carolina, after a recent mice model experiment of theirs returned promising results. Their study claims that CBD dosing was able to reduce seizures and abnormal …
Read More »
USA, July 11, 2019 (MARIJUANA BUSINESS DAILY)- While the hot streak of capital raises may have chilled slightly in recent weeks, the North American cannabis industry is still far outpacing last year’s totals in terms of overall money raised. So far in 2019, total raises were led by $5.2 billion …
Read More »
Australia, July 8, 2019 (HEMPGAZETTE)- The legalising of cannabis in Canada for the recreational market has apparently impacted on accessibility to medical cannabis – and created other issues. A survey commissioned by Canadians for Fair Access to Medical Marijuana (CFAMM), the Arthritis Society and the Canadian Pharmacists Association (CPhA) carried …
Read More »Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.
Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.
Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.
Investment Value Finders is intended for those 21+ years of age only!
Investment value finders Investment value finders